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Abstract
Homologous recombination (HR) is critical for the repair of double strand breaks and broken replication forks. Although HR
is mostly error free, inherent or environmental conditions that either suppress or induce HR cause genomic instability.
Despite its importance in carcinogenesis, due to limitations in our ability to detect HR in vivo, little is known about HR in
mammalian tissues. Here, we describe a mouse model in which a direct repeat HR substrate is targeted to the ubiquitously
expressed Rosa26 locus. In the Rosa26 Direct Repeat-GFP (RaDR-GFP) mice, HR between two truncated EGFP expression
cassettes can yield a fluorescent signal. In-house image analysis software provides a rapid method for quantifying
recombination events within intact tissues, and the frequency of recombinant cells can be evaluated by flow cytometry. A
comparison among 11 tissues shows that the frequency of recombinant cells varies by more than two orders of magnitude
among tissues, wherein HR in the brain is the lowest. Additionally, de novo recombination events accumulate with age in
the colon, showing that this mouse model can be used to study the impact of chronic exposures on genomic stability.
Exposure to N-methyl-N-nitrosourea, an alkylating agent similar to the cancer chemotherapeutic temozolomide, shows that
the colon, liver and pancreas are susceptible to DNA damage-induced HR. Finally, histological analysis of the underlying cell
types reveals that pancreatic acinar cells and liver hepatocytes undergo HR and also that HR can be specifically detected in
colonic somatic stem cells. Taken together, the RaDR-GFP mouse model provides new understanding of how tissue and age
impact susceptibility to HR, and enables future studies of genetic, environmental and physiological factors that modulate
HR in mammals.
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Introduction
DNA is constantly subjected to endogenous and environmental
DNA damaging agents that can lead to toxicity, mutations, and
ultimately disease [1]. Maintaining genomic stability in the face of
the thousands of DNA lesions that are formed in each cell every
day poses a major challenge, especially in the case of double strand
breaks (DSBs), which are acutely toxic and can lead to the loss of
millions of base pairs if a portion of a chromosome is lost [1,2].
The two major pathways used by cells to repair DSBs are non-
homologous end-joining (NHEJ), which directly rejoins DNA
ends, and homologous recombination (HR), which requires a
homologous duplex for DSB repair [3–8]. The correct balance of
NHEJ and HR is essential for preventing genomic instability [4,9].
If there is a deficiency in HR (e.g., loss of function of BRCA2), cells
can suffer misrepair of DSBs, resulting in cytotoxicity and
translocations that promote cancer and aging [10–12]. Ironically,
despite the fact that HR is essential, too much HR can also be
detrimental, since HR carries the risk of misalignments that cause
insertions, deletions, as well as loss of heterozygosity (LOH)
[13,14]. It is likely that HR events contribute to sequence changes
in virtually all cancers, since loss of function of almost all tumor
suppressor genes requires LOH, and many, if not most, LOH
events are caused by HR [14–16]. Further, sequence changes
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generated by HR have been found in multiple cancers [17–22],
and many conditions that promote HR also promote cancer (as a
few examples, exposure to UV light [23,24], exposure to
benzo[a]pyrene [25,26] and mutations in BLM [27] and Ku70/
80 [28,29]).
Dozens of genes are either directly involved in HR or modulate
HR activity [6,30]. An essential early step in HR is the resection of
double strand ends to create a 39 single stranded overhang [31,32].
Subsequently, BRCA2 helps to load RAD51 onto the single
stranded DNA to form a nucleoprotein filament that is capable of
homology searching [33–37]. Strand invasion leads to formation
of a D-loop that is then either resolved by synthesis-dependent
strand annealing, which is not associated with crossovers, or by
second-end capture and formation of a double Holliday junction,
which may or may not be associated with a crossover [5,30,38–
40]. Although crossovers during HR are relatively rare [4,41],
HR-associated crossovers have been shown to cause LOH [14–
16,20]. In addition to its important role in the repair of two-ended
double strand breaks, HR is essential for repair of one-ended
double strand breaks that arise as a consequence of replication fork
breakdown [5,30,42]. In HR deficient cells, such broken ends
cannot be faithfully repaired via reinsertion into the sister
chromatid, leading to an increase in misrepair via joining to an
inappropriate end [4,9,30]. Despite HR’s critical role in main-
taining genomic stability, little or nothing is known about HR
activity in most tissues in vivo, due to the lack of effective tools for
studying HR in mammals.
Using mouse models that harbor sequences amenable to studies
of HR, key insights about HR in vivo have been gleaned for certain
cells types and tissues. In pioneering work by the Schiestl
laboratory, pun mice, which carry a natural duplication wherein
a change in pigmentation indicates an HR event, have been used
to study the impact of genes and exposures on HR [43,44].
Additionally, mice engineered to be heterozygous at the Aprt locus
have been used to show that LOH is often driven by HR in vivo
[45,46]. More recently, our laboratory set out to create mouse
models in which HR can be detected via direct repeat HR
reporters.
Studies in S. cerevisiae first demonstrated that direct repeat
substrates are useful for studying HR [47–49]. Briefly, two
expression cassettes for a selectable marker are integrated into
the genome adjacent to each other. Each expression cassette lacks
sequences that are essential for expression. If the expression
cassettes misalign and undergo homologous recombination,
sequence information can be transferred from one cassette to the
other, which can reconstitute full-length sequence to enable
expression of the selectable marker (e.g., Figure 1A; black bars
indicate deleted sequences). Studies exploiting direct repeat HR
substrates in mammalian cells have given rise to fundamental
information about the mechanism of HR as well as the impact of
sequence orientation, distance between repeats, and exposures on
HR [50–53]. The Nickoloff laboratory incorporated a site for the
homing endonuclease I-SceI, which creates a double strand break
that induces HR. Controlling the position of the double strand
break gave rise to additional insights into the underlying
mechanisms of HR [54,55]. More recently, the Jasin laboratory
designed HR substrates wherein a site-specific double strand break
induces HR events that can be detected by expression of EGFP
[56], and these assays have been used extensively to reveal the
genetic underpinnings of HR [4]. We later created a plasmid-
based fluorescence recombination assay which was used for studies
of the impact of inflammatory chemicals on HR [57]. To move
from in vitro studies to in vivo studies, we subsequently used elements
of the plasmid assay to create a fluorescence-based direct repeat
HR substrate in mice. The fluorescent yellow direct repeat
(FYDR) mice carry a direct repeat substrate wherein HR can lead
to the reconstitution of the full-length coding sequence of the
enhanced yellow fluorescent protein (EYFP) gene [58,59]. The
FYDR mice are the first genetically engineered animal model that
specifically detects HR, and the FYDR HR substrate intentionally
does not include a site for artificial introduction of a double strand
break (e.g., via I-SceI), since our primary objective is to enable
studies of environmental, genetic and physiological factors that
modulate HR.
The use of fluorescence has proved to be an effective approach
for detecting HR in the FYDR mice in vivo [58,60–63]. As
expected [50], spontaneous recombination at the HR substrate is
rare (the frequency of recombinant cells is ,1/105) [58,59].
Nevertheless, the frequency of recombinant cells can be quantified
by flow cytometry, and a fluorescent readout makes it possible to
identify the cell types that have undergone HR within intact tissue
via histological analysis. Furthermore, independent recombination
events (as opposed to frequency of cells harboring recombinant
DNA) are detectable as fluorescent foci in freshly excised intact
tissue by imaging whole organs [60,61]. To learn more about the
factors that impact the frequency of recombinant cells, we also
developed a 3D imaging platform for intact tissue, which made it
possible to determine how many recombinant cells result from de
novo recombination events versus cell division [64]. These studies
showed that both de novo recombination and clonal expansion drive
the accumulation of recombinant cells with age [61,64]. Taken
together, studies using the FYDR mice show that fluorescence
detection of HR in vivo provides valuable insights into genetic,
environmental and physiological factors that modulate HR [58–
60,62,63]. Importantly, however, only a limited number of tissues
can be studied in the FYDR mice as a consequence of poor
expression in some tissues (presumably due to the random locus
integration following pronuclear injection) [58,65]. We therefore
set out to generate a recombination reporter mouse with broad
reporter expression.
In order to create a mouse model in which HR can be studied in
virtually any cell type, we created targeting vectors to enable
Author Summary
Cancer is a disease of the genome, caused by accumulated
genetic changes, such as point mutations and large-scale
sequence rearrangements. Homologous recombination
(HR) is a critical DNA repair pathway. While generally
accurate, HR between misaligned sequences or between
homologous chromosomes can lead to insertions, dele-
tions, and loss of heterozygosity, all of which are known to
promote cancer. Indeed, most cancers harbor sequence
changes caused by HR, and genetic and environmental
conditions that induce or suppress HR are often carcino-
genic. To enable studies of HR in vivo, we created the
Rosa26 Direct Repeat-Green Fluorescent Protein (RaDR-
GFP) mice that carry an integrated transgenic recombina-
tion reporter targeted to the ubiquitously expressed
Rosa26 locus. Being able to detect recombinant cells by
fluorescence reveals that the frequency of recombination
is highly variable among tissues. Furthermore, new
recombination events accumulate over time, which con-
tributes to our understanding of why our risk for cancer
increases with age. This mouse model provides new
understanding of this important DNA repair pathway in
vivo, and also enables future studies of genetic, environ-
mental and physiological factors that impact the risk of
HR-induced sequence rearrangements in vivo.
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integration of a direct repeat recombination reporter into the
Rosa26 locus [66]. Here we describe the Rosa26 Direct Repeat-
Green Fluorescent Protein (RaDR-GFP) mice, which harbor
two uniquely truncated EGFP expression cassettes in tandem.
HR at the direct repeat can reconstitute full-length EGFP
coding sequence, giving rise to fluorescence (Figure 1A). Using
this system, we were able to quantify HR in all tissues tested
using flow cytometry. Furthermore, we show that several
tissues are susceptible to DNA damage-induced HR, and using
a novel automated image analysis program for analysis of
fluorescence within intact tissue, we show that HR events
accumulate in the somatic stem cells of the colon. The RaDR-
GFP mice therefore open doors to studies of exposure-induced
HR and make it possible to perform an integrated analysis of
how cell type, tissue type and age impact HR in vivo. Together
with the development of quantitative approaches for assessing
HR, the RaDR-GFP mice enable studies of how genetic and
environmental factors modulate susceptibility to HR events in
cancer-relevant tissues.
Results
Creation of the RaDR-GFP Mouse
To study recombination in vivo, we previously created a
direct repeat substrate in which two EGFP expression cassettes
are positioned in tandem (Figure 1A) [66]. Essential sequences
were deleted from each of the EGFP cassettes to create D5egfp,
which lacks 15 bp at the 59 end, and D3egfp, which lacks 81 bp
at the 39 end. Recombination between the non-functional
expression cassettes can reconstitute full-length coding se-
quence, which can then be expressed under the CMV
enhancer/chicken beta-actin promoter [CAG] (Figure 1B)
[66,67]. The promoter, intron, and polyadenylation signal
sequences are the same as for the established FYDR mouse
model [58]. In the FYDR model, expression levels were high in
some tissues (such as pancreas), but there was almost no
expression in other tissues (such as the colon), presumably as a
consequence of gene silencing associated with the locus of
integration.
To enable broad expression, we targeted the HR reporter to
the Rosa26 locus, which was originally identified for its nearly
ubiquitous expression [68]. Using a Rosa26 targeting construct
(a kind gift from Dr. P. Soriano) [68], we previously created a
targeting vector that includes a short arm (SA), a positive
selection marker (NeoR), a direct repeat HR substrate, a long
arm (LA), and a negative selection cassette (diphtheria toxin
fragment A; DTA) (Figure 1C) [66]. The construct design
strategy is shown in Figure S1. While our prior studies were
focused on HR in ES cells in vitro, here we set out to create a
knock-in mouse. The targeting construct was electroporated
into mouse 129S4/SvJae (129 background) ES cells. Out of
100 colonies, we identified seven candidates using primers
designed to yield a 1.16 kb product from wild type DNA and a
1.24 kb product from the targeted allele (Figure 1C–D). Five
out of seven candidates harbored the diagnostic 8.2 and a
2.3 kb HindIII fragments when analyzed by Southern blot
(Figure 1C and 1E). Ten to fourteen 129 ES cells were injected
into 3.5-day-old C57BL/6 blastocysts, and the resultant
chimeric males were bred with 129 females to establish the
RaDR-GFP mouse line. While the 129 background was
maintained, the transgene was also backcrossed into the
C57BL/6 background for 10 generations. The transgene
follows Mendelian inheritance with 49.5% of offspring of
heterozygous/wild type parents inheriting the transgene
(n = 99).
Expression of EGFP in RaDR-GFP Mouse Fibroblasts Is
Caused Specifically by HR
To initiate studies of HR in the RaDR-GFP mice, we first
analyzed primary ear fibroblasts. Cells were harvested, expanded
in culture, and examined by flow cytometry. Gates defining ‘green
fluorescent’ and ‘autofluorescent’ cells were drawn conservatively
to prevent autofluorescent from being identified as fluorescent,
Figure 1. Targeted integration of the RaDR-GFP HR substrate.
(A) The RaDR-GFP HR substrate consists of two EGFP expression
cassettes arranged in tandem (large arrows), each of which is missing
essential sequences: deletions at the 59 (D5) and 39 (D3) ends of the
coding sequences are indicated by black bars. Coding sequences are in
green, and the CAG promoter and polyadenylation (pA) signal
sequences are in white. (B) Most cells harboring the RaDR-GFP
substrate are non-fluorescent (top) while rare HR events give rise to
fluorescent cells (bottom). (C) The RaDR-GFP targeting vector (top) is
comprised of a Rosa26 short arm (SA), a positive selection cassette
(NeoR), the GFP direct repeat HR substrate (described in A), a long arm
(LA) and the diphtheria toxin fragment A (DTA) negative selection
cassette. Targeted integration gives rise to an 8.2 and 2.3 kb HindIII (H)
fragment. PCR primers (small arrows) amplify the wild type genomic
DNA (1.16 kb) whereas the targeted allele is amplified when a third
primer (black triangle) is opposed to the forward primer to give rise to a
1.24 kb product. (D) PCR analysis of a positive control clone, wild type
cells and two examples of targeted clones. (E) HindIII digested genomic
DNA probed with the EGFP cDNA reveals 8.2 and 2.3 kb fragments
specific to correctly targeted clones.
doi:10.1371/journal.pgen.1004299.g001
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while capturing the majority of the EGFP expressing cells
(Figure 2B).
To formally determine whether or not green fluorescent cells
had indeed undergone HR, we isolated fluorescent cells to
learn if they harbor full-length EGFP coding sequence. We
previously designed PCR primers that specifically amplify
D3egfp, D5egfp, or full-length EGFP (Figure 2A and Table S1).
Here, we developed methods to analyze cells for the presence
or absence of each cassette using cDNA as a template, rather
than genomic DNA as previously described [66]. Our rationale
for this approach was that by exploiting the multiple copies of
cassette sequences present in mRNA, we would be able to
query the presence and absence of cassettes in single cells in
future experiments. As a first step, primers were used to
analyze cDNA from control ES cell lines that had previously
been targeted with each cassette individually, as well as ES
cells that harbor both D3egfp and D5egfp [66]. Conditions were
optimized so that both D3egfp and D5egfp are detectable in a
single PCR reaction so that each cassette serves as a positive
control for the other. Results show specific detection of each
cassette in isolation and together, and full length sequence is
only observed in the positive control EGFP expressing cells, as
expected (Figure 2C, first five panels). To create the RaDR-
GFP mice, we created new early passage clones of ES cells
targeted with the recombination substrate. PCR analysis of
RaDR-GFP cells that carry the unrecombined substrate
reveals both the D3egfp and D5egfp cassettes, but not the full
length EGFP, as expected (Figure 2C, panel six).
Having created RaDR-GFP mice that carry the Rosa26
targeted HR substrate (Figure 1C–E), we next set out to
determine whether or not fluorescent cells from these animals
indeed harbor the full length EGFP sequence, as anticipated
following HR. Fluorescent and autofluorescent control cells
were isolated from a single cell suspension of disaggregated
RaDR-GFP pancreatic cells using FACS (Figure 2B). Primers
that flank the coding sequence were optimized for nested PCR
(Table S2), and cDNA was analyzed either by direct PCR or
nested PCR, as indicated. Analysis of autofluorescent RaDR-
GFP pancreatic cells revealed the presence of D3egfp and D5egfp,
whereas full-length EGFP sequence was not detected (Figure 2D).
In contrast, full-length EGFP was readily detected in samples of
green fluorescent RaDR-GFP pancreatic cells (Figure 2D). The
D3egfp and D5egfp cassettes were also detected (Figure 2D),
which is consistent with their potential retention following HR
(Figure 1A). The RaDR-GFP HR substrate is designed so that
over a dozen base pairs need to be restored to give rise to a
functional full-length EGFP coding sequence [66]. As restoration
of a significant number of nucleotides requires HR for
Figure 2. HR leads to reconstitution of full-length EGFP coding sequence within green fluorescent RaDR-GFP pancreatic cells. (A) PCR
primers (P1–P6) that specifically amplify full length EGFP, D3egfp, and D5egfp yield the indicated sized fragments (see [66]). Hatched regions indicate
unique sequences inserted at the site of the deletions enabling the design of cassette specific primers. (B) Relative fluorescence intensity for 515–
545 nm (y axis) and 562–588 nm (x axis), respectively. Expression of EGFP leads to a shift to the right. Bracket is drawn to capture the majority of the
green fluorescent EGFP positive cells, while excluding autofluorescent cells. (C) PCR analysis using primers that specifically amplify D3egfp, D5egfp,
and full length EGFP to yield a 415, 250 and 740 bp product, respectively. Products are not observed in WT cells (left panel; ladder in lane 1). PCR
analysis of targeted clones that each harbor the indicated cassettes demonstrates the specificity of the PCR conditions for each cassette. ES cells used
to create the RaDR-GFP mice harbor the D3egfp and D5egfp cassettes, consistent with the presence of the unrecombined HR substrate. (D)
Fluorescence activated cell sorting and PCR of autofluorescent and green fluorescent pancreatic cells from RaDR-GFP mice reveals the presence of
the D3egfp and D5egfp cassettes (from the unrecombined HR substrate). Full length EGFP coding sequence is uniquely present in the population of
green fluorescent cells, consistent with reconstitution of full-length EGFP sequence following HR.
doi:10.1371/journal.pgen.1004299.g002
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alignment and transfer of sequence information, these data show
that fluorescence is an indicator of homologous recombination
at the RaDR-GFP substrate.
Ultimately, this mouse model can be used to study the
underlying molecular changes that caused sequences to be restored
to full length. Gene conversions without a crossover can be
identified by the presence of one of the two original cassettes,
along with full-length sequence. In contrast, replication fork repair
or gene conversion with crossover will result in a triplication
wherein both of the original cassettes are present along with the
full-length sequence (Figure 3). We had previously performed this
type of analysis on ES cells that had been clonally expanded in vitro
[66]. Here, we set out to develop methods that would enable
studies of HR in vivo. Because clonally expanding single cells from
mouse tissues is difficult, we set out to develop methods that would
enable analysis of single fluorescent cells isolated from mouse
tissues using FACS. Initial data indicate that single cell analysis
can indeed be used to identify cells with each of the three major
recombination classes (Figure S2B).
Positive Control Mice Reveal Broad Expression of EGFP In
Vivo
Previous studies of FYDR positive control mice (which express
EYFP from the same promoter and locus as the HR reporter) show
that there is little or no expression of EYFP in many tissues
(presumably due to silencing), which greatly limits the utility of the
FYDR model [65]. While we anticipated that targeting the EGFP
direct repeat reporter to a site with ubiquitous expression would
overcome this barrier to studies of HR, prior studies of expression
at the Rosa26 locus had been done using the Rosa26 promoter [68],
whereas the CAG promoter drives the RaDR-GFP transgene. To
address the formal possibility that EGFP expression from the
RaDR-GFP reporter might not be ubiquitous, we assessed the
extent of expression of EGFP from a positive control mouse in
which EGFP is expressed specifically from the CAG promoter at
the Rosa26 locus (see Materials and Methods for details). Analysis
of tissues from the FYDR positive controls showed high expression
of EYFP in the pancreas, and low expression in the liver and the
colon (Figure 4A, upper row), which is similar to the low
expression previously observed in the kidney and lung [65]. In
contrast, expression of EGFP in the Rosa26 positive control mice
was very strong in all three tissues (Figure 4A, bottom row). By
using the same imaging parameters, these data also show that
fluorescence from EGFP is significantly brighter than that of
EYFP. Analysis by flow cytometry similarly shows that EGFP
fluorescence is high not only in pancreas, liver and colon
(Figure 4B), but also in eight additional tissues (Table 1). The
nearly ubiquitous expression of EGFP in the positive control mice
suggests that fluorescent recombinant cells in the RaDR-GFP mice
would be detectable in most mouse tissues. Furthermore, the
positive control mice are essential for comparisons of HR
frequency among tissues, since the frequency of GFP positive
cells in the positive control mice provides the required baseline for
comparing HR frequencies among tissues in the RaDR-GFP
mouse model.
HR Is Detected in 11 Major Organs and Tissues
To explore the feasibility of studying HR in multiple tissues
(including tissues that had previously been inaccessible to HR
analysis), 11 tissues from RaDR-GFP mice were disaggregated
and analyzed by flow cytometry, first by gating for live cells,
and subsequently by gating for fluorescent cells. Remarkably,
fluorescent recombinant cells were present in all tissues
(Figure 4C). Recombinant cells were relatively frequent in
the pancreas (similar to the FYDR mice) and in the spleen.
Recombinant cells were also observed at a significant
frequency in the kidney, heart, liver, mammary gland, and
colon of the RaDR-GFP mice (all of which had previously been
inaccessible for studies of HR within mammalian tissues in
vivo). In contrast, very few fluorescent cells were detected in
stomach or brain tissue (Figure 4C). The observation that
,90% of cells from brain tissue of the Rosa26 positive control
mice are fluorescent (Table 1) indicates that fluorescent
recombinant cells can be detected. These results together
therefore show that there are very few recombinant cells in the
brain (note that the detection of rare fluorescent cells is limited
to ,1/106). One possible explanation for the low frequency of
Figure 3. HR at the RaDR-GFP substrate can give rise to
fluorescence following gene conversion, sister chromatid
exchange, and replication fork repair, but not following SSA.
Each cassette is missing different essential coding sequences such that
neither is able to express EGFP. Gene conversion can lead to transfer of
sequence information from one cassette to the other, restoring full-
length EGFP coding sequence and giving rise to a fluorescent readout.
Each cassette can be the donor or the recipient in a gene conversion
event. The entire HR reporter is copied during S phase, making it
possible for crossovers between sister chromatids (gene conversion
with crossover) to reconstitute full-length EGFP. Note that a long tract
gene conversion event would be indistinguishable. Recombination that
arises as a consequence of repair of a broken replication fork can also
be detected using the RaDR-GFP substrate. A replication fork
breakdown arising from a fork moving from left to right is shown.
Reinsertion of the broken D3egfp end into the D5egfp cassette can
restore full length EGFP. Note that this figure depicts events wherein
the replication fork had been moving from left to right; EGFP can
analogously be restored by repair of forks moving in the opposite
direction (not shown). Single strand annealing initiated by a DSB
between the repeated cassettes can be readily repaired, but these
events will not reconstitute full-length EGFP and thus SSA cannot be
detected.
doi:10.1371/journal.pgen.1004299.g003
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EGFP positive cells in the brain is the short time period during
which HR is active in the developing brain [69], where it plays
a critical role in neurogenesis and cancer suppression [70]. It is
possible that relatively few recombinant cells accumulate in the
RaDR mouse brain compared to other tissues due to the short
time during which HR is highly active. Although further
studies are needed for a more in depth understanding of HR
among tissues, taken together, these studies show for the first
time that spontaneous HR is pervasive in adult mammalian
tissues.
Visualization of Recombinant Cells within Intact Tissues
Enables Quantification of HR Events
Our previous studies, as well as results presented here, show
that recombinant cells can be detected in situ within intact
pancreata of FYDR mice as fluorescent foci (Figure 5A) (see
Figure 4. Analysis of EYFP and EGFP positive control mice and RaDR-GFP tissues. (A) Histological images of FYDR positive control mice
that harbor full-length EYFP sequences within mouse Ch. 1, and RaDR-GFP positive control mice that harbor full-length EGFP at the Rosa26 locus
expressed under the same CAG promoter (see Materials and Methods). Brightness/contrast for EYFP filtered images (610) was adjusted equivalently
for all images. (B) Quantification of percentage of cells that are fluorescent within disaggregated pancreas, liver and colon of the FYDR and RaDR-GFP
positive control mice (measured using flow cytometry). Almost no cells are fluorescent in liver and colon cells from the positive control FYDR mice,
indicating that these tissues cannot be used for analysis of HR in the FYDR mice. Almost all cells from the pancreas, liver and colon of the RaDR-GFP
positive control mice are fluorescent, indicating that these tissues can be analyzed for HR frequency in the RaDR-GFP mice. (C) Frequency of HR
among 11 different tissues from two months old RaDR-GFP mice is highly variable. The number of recombinant cells per million is reported as
individual data points (one data point for each mouse; samples from 9–10 mice were analyzed for each type of tissue). Horizontal lines that capture
more than one tissue type indicate that samples within that group are not statistically significantly different from one another. Statistically significant
differences between groups (of one or more tissue types) are noted. Bars indicate median frequencies.
doi:10.1371/journal.pgen.1004299.g004
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Table 1. Percentage of fluorescent cells in disaggregated RaDR-GFP tissues.
Tissue Fluorescent (%)
Brain 9166
Breast 8769
Colon/Cecum 9064
Heart 74618
Kidney 7969
Liver 86610
Lung 79618
Pancreas 9465
Spleen 8362
Stomach 75624
Thymus 83613
Tissue was disaggregated and analyzed by flow cytometry. Gating to capture EGFP positive cells was set to stringently exclude autofluorescent cells from wild type mice
(see Materials and Methods for details).
doi:10.1371/journal.pgen.1004299.t001
Figure 5. Fluorescence detection of recombinant cells within intact tissues of FYDR and RaDR-GFP mice and identification of the
underlying cell types. (A) Analysis of pancreatic tissue from FYDR mice. Foci can be detected within images of the entire organ compressed to
0.5 mm (left image is at61, scale bar = 1 cm). Foci are readily quantifiable at65 (middle image, scale bar = 1 mm). Histological image of H&E stained
section (right image at660, scale bar = 20 mm) overlaid with fluorescence image (510–560 nm filter). Brightness/contrast for fluorescent images was
optimized for each histological section. Fluorescence is pseudocolored. (B) Analysis of pancreatic tissue (nearly the entire organ) from a RaDR-GFP
mouse compressed to 0.5 mm. Nuclei are stained with Hoechst; fluorescent recombinant cells are pseudocolored green. (C) In situ detection of
recombinant cells within pancreas, liver and colon from RaDR-GFP mice. Image collection was done according to (A). Recombinant pancreatic acinar
cells, liver hepatocytes and colonic epithelial cells are quantifiable within freshly excised tissues (left and middle images). Cell types can be discerned
using H&E overlay (right images). (D) Crypt model emphasizing that recombinant transit cells are rapidly lost, while recombinant somatic stem cells
can give rise to a persistent wholly fluorescent crypt. (E) Analysis of disaggregated crypts reveals the presence of non-fluorescent crypts (left) and
crypts in which essentially all of the epithelial cells fluoresce (right).
doi:10.1371/journal.pgen.1004299.g005
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[60,61]). Importantly, since recombination is a rare event and
pancreatic cells do not migrate significantly, independent
recombination events can be identified as isolated fluorescent
foci. Analysis of recombination events provides greater sensitivity
compared to the frequency of recombinant cells as a means for
detecting genetic and environmental factors that modulate HR
[65].
To explore the efficacy of RaDR-GFP mice for studies of HR
events within intact tissue, pancreatic tissue from a RaDR-GFP
mouse was stained with DAPI and imaged using fluorescence
microscopy at low magnification (61). Fluorescent foci are readily
apparent in the RaDR-GFP pancreatic tissue (Figure 5B). Tissue
from 11 RaDR-GFP mice was compressed to 0.5 mm and imaged
for manual quantification of foci. Using this approach, we
observed that the median frequency of spontaneous recombination
events is ,140/cm2. In addition, unlike the FYDR mice,
recombinant foci are also readily detected in both the intact liver
and the intact colon (Figure 5C).
Differences in the frequency of foci among tissues reflect both
the frequency of HR events as well as the optical properties of each
tissue. Therefore, it is difficult to discern tissue-specific differences
in HR using this approach (note that flow cytometry of
disaggregated tissues overcomes this limitation). Importantly,
however, for studies of factors that modulate HR in a specific
tissue, analysis of HR events in situ provides a powerful approach
both in terms of increased sensitivity [65] and in terms of learning
about HR in specific cell types (see below).
Histological Identification of Recombinant Cell Types
Although HR events are rare, it is nonetheless possible to
identify fluorescent foci within frozen 5 mm sections using
epifluorescence microscopy. After imaging, sections can be stained
with hematoxylin and eosin (H&E) to reveal tissue architecture.
Image overlays for pancreatic fluorescent foci reveal that for both
FYDR and RaDR-GFP, recombination is detected in pancreatic
acinar cells (Figure 5A and 5C, right). These observations are
consistent with studies of FYDR mice in which analysis of .100
pancreatic foci revealed only acinar cells [61]. In the case of liver
and colon, overlay of fluorescent images with H&E images reveals
fluorescent hepatocytes in the liver, and fluorescent epithelial cells
in the colon (Figure 5C). Pancreatic acinar cells, liver hepatocytes
and colonic epithelial cells all give rise to tumors in their respective
tissues, raising the possibility that the RaDR-GFP mice can be
used to study the etiology of cancer (see Discussion).
Detection and Quantification of HR Specifically within
Somatic Stem Cells
Somatic stem cells are of particular interest in cancer research.
In the colon, there are only one or a few somatic stem cells at the
base of each colonic crypt. Somatic stem cells are defined as being
cells that have the ability to give rise to the epithelial layer in that
crypt [71–73]. Therefore, a single HR event in a colonic somatic
stem cell can lead to ‘‘crypt conversion’’ wherein all of the
epithelial cells of its crypt share the same genetic change
(Figure 5D). Since transit cells are short lived, lasting only a few
days before the epithelial layer of the crypt is replaced [73],
mutations in transit cells are less likely to contribute to cancer
compared to mutations in colonic somatic stem cells, which can
persist throughout the lifetime of the animal [73].
Analysis of thin sections via epifluorescence microscopy revealed
a cross section of a colonic crypt in which it appears that all of the
central epithelial cells are fluorescent (Figure 5C, bottom right),
suggesting that a stem cell from this crypt replaced the
crypt epithelial cell layer with fluorescent daughter cells (crypt
boundaries can be identified by a ring of epithelial cells with higher
staining intensity; Figure 5C). To learn more about the possibility
of crypt conversion, colonic tissue was processed to gently remove
crypts. Intact wholly fluorescent crypts were readily identified
among disaggregated crypts from RaDR-GFP mice (e.g.,
Figure 5E), which is consistent with replacement of crypt epithelial
cells by a single somatic stem cell that had undergone HR at the
RaDR-GFP substrate. Taken together, the RaDR-GFP mice
enable studies of HR in a cell type that is highly relevant to colon
cancer.
Recombinant Somatic Stem Cells Accumulate with Age
in the Colon
Aging is a critical risk factor for almost all cancers. To learn
about the potential for recombinant cells to accumulate with age in
the colon, we imaged and analyzed colonic tissue from young (3–4
months old) and old (9–10 months old) animals. Foci were counted
by eye in a blinded fashion, and results indicated that there was no
significant difference in the frequency of recombinant cell foci
between the young and old animals (Figure 6D, left). Foci in
colonic tissue appear both as a consequence of transit cell
recombination and somatic stem cell recombination. Given that
transit cells are only present for a few days, unless the rate of
recombination changes for young and old animals, one would not
anticipate an observable increase in the frequency of transit cell
foci. In contrast, as described above, somatic stem cells can persist
for years [73], which raises the possibility that fluorescent foci that
result from recombination events in stem cells would accumulate
and be detectable by the presence of whole crypt conversion. In
order to favor detection of HR events in somatic stem cells, we
therefore set out to create an image analysis program that
differentiates large foci (more likely to be due to whole crypt
conversion) from small foci (more likely to be the result of HR in
transit cells).
We created a foci counting program that favors detection of
large foci by using automated quantification techniques that
exploit both intensity and morphological features. Classification
was enabled using support vector machines. We simulated the data
using a noise model, which includes the homogenous noise of the
sample as well as the detection noise, to analyze the performance
of our algorithms. To avoid false positives, only large foci with a
consistent morphology and intensity were counted, and small foci
or irregularly shaped foci were excluded (Figure 6A). Although this
approach has a potentially high false negative frequency, it is more
important to avoid false positives than false negatives. Analysis of
the lumen of large samples of colonic tissue shows the clear
appearance of bright foci (Figure 6B). Using the automated
analysis software, large foci were marked with a dark cross if
considered to be positive (Figure 6C). Direct comparison of
Figure 6B and Figure 6C shows that the majority of the large foci
are identified by the program. We validated this approach by
comparing the automated counting results to manual counts. A
more detailed description of this software will be published
separately.
Using our image analysis software, we reanalyzed the colonic
tissue from young and old mice. Remarkably, there is a highly
significant (p,0.01) increase in the frequency of larger foci with
age (Figure 6D, right). Since the largest foci result from clonal
expansion of somatic stem cells, these results indicate that
recombination events indeed accumulate in colonic somatic stem
cells. It is noteworthy that inclusion of foci from transit cells is
anticipated to lead to smaller foci that mask detection of changes
in the more rare larger foci, as indicated in Figure 6D (left) such
that inclusion of false positives damps the signal from the somatic
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stem cells. Taken together, these results provide some of the first
insights into the relative susceptibility of transit cells and somatic
stem cells to recombination with age, and open doors to future
studies of conditions that modulate the risk of recombination in
cells that have the potential to give rise to cancer.
RaDR-GFP Mice Enable Studies of Exposure-Induced HR
in Multiple Tissues
Alkylating agents are carcinogenic, used for cancer chemother-
apy, and have been shown to be recombinogenic in mice [74,75].
We were therefore interested in the extent to which RaDR-GFP
tissues would be susceptible to exposure-induced HR. Here, we
focused on methylnitrosourea (MNU), a model SN1 alkylating
agent similar to temozolomide, which is used in cancer chemo-
therapy [74]. In parallel ongoing studies of FYDR mice, we tested
multiple exposure conditions for efficacy in inducing HR, and we
found that the combination of MNU and thyroid hormone (T3),
which impacts pancreas physiology, was the strongest inducer of
HR among the conditions that we tested. We therefore asked
whether or not the RaDR-GFP model is sensitive to exposure-
induced HR by treating animals with combined MNU/T3 (see
Materials and Methods). In addition to pancreas, we also
evaluated colon and liver (Figure 7A). For all three tissues,
MNU/T3 was a strong inducer of HR. For the pancreas, the
increase in the frequency of de novo recombination events was most
dramatic (Figure 7B), making it infeasible to quantify recombinant
foci manually. Automated image analysis using a modified version
of our foci analysis program (optimized for the pancreas) enables
quantification of small/faint foci that are difficult to quantify by
eye (Figure 7C). Furthermore, the automated foci counting
program enables future studies of foci characterization based on
size and other morphological characteristics. Automated quanti-
fication of foci in RaDR-GFP mouse pancreata shows that, on
average, exposure to MNU/T3 leads to ,400 new recombination
events per cm2 (Figure 7D). In addition to the pancreas, exposure-
induced HR was also observed in the liver and colon of RaDR-
GFP mice (Figure 7D). Taken together, these results demonstrate
the efficacy of RaDR-GFP mice for studies of exposure-induced
HR in multiple tissues.
Discussion
Although HR is essential [76,77], its activity must be carefully
controlled in order to maintain genomic integrity [30,70].
Inherent defects that either suppress or induce HR are known to
be tumorigenic [11] and exposures that induce HR are often
carcinogenic [22,44]. Despite its importance, progress in our
understanding of the role of HR in mammals has been hampered
Figure 6. Recombinant cells accumulate with age in the colon.
(A) Image analysis with in-house software designed to detect large foci
with consistent morphology. Note that small foci and irregularly shaped
foci are not designated positive by the program (compare left and right
images; ‘‘+’’ symbols indicate foci identified by the program). (B) Freshly
excised colonic tissue opened to reveal the lumen is pressed between
coverslips and imaged using an epifluorescent microscope. (C) Image
analysis using in-house software marks large foci with a dark cross.
Comparing B and C shows that most of the large foci (bright white
spots) are recognized by the program (dark cross marks). (D)
Quantification of recombination events by analysis of foci frequency
in the colon. Each symbol indicates the foci frequency for tissue from a
single mouse (N= 5–6). The entire surface area was imaged in order to
suppress the impact of variation in different regions of each tissue.
Images were compiled, and the frequency of foci was determined for
the entire organ, which was then divided by the surface area
(determined using ImageJ). Each symbol represents the average
number of foci/cm2 for the entire organ from each animal in cohorts
of juvenile and aged animals. Bars indicate medians. Both small and
large foci were counted manually (left). The same samples, when
analyzed using in-house software that identifies large crypts, shows a
statistically significant increase in the aged animals (p,0.01, Student’s t-
test) (right). Large foci are consistent with HR in colonic somatic stem
cells that lead to wholly fluorescent crypts.
doi:10.1371/journal.pgen.1004299.g006
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by the lack of effective tools for studying HR in many mammalian
tissues. Here, we describe the RaDR-GFP mice, which harbor an
integrated direct repeat that causes cells to fluoresce following HR.
By targeting the reporter to the Rosa26 locus, expression of the
transgene is nearly ubiquitous, thus enabling studies of HR in
nearly all major organs, including liver, colon, spleen, heart, lung,
kidney, stomach, thymus, brain, breast, and pancreas, many of
which have been hitherto inaccessible for analysis.
HR events at the RaDR-GFP substrate can occur via several
different mechanisms. Prior studies of ES cells show that most
recombinant fluorescent RaDR-GFP cells have undergone
gene conversion without crossovers [66], which are thought to
result primarily from the synthesis dependent strand annealing
pathway (see [5], which includes animations for HR pathways).
DSB-induced crossovers between sister chromatids can also be
detected by the RaDR-GFP substrate. Importantly, one of the
critical roles of HR is to repair one-ended DSBs at broken
replication forks, and these events can readily be detected
using the RaDR-GFP substrate (Figure 3). One challenge when
using the direct repeat approach for studies of HR is that these
canonical HR events can be overshadowed by single strand
annealing (SSA), a subpathway of HR that is the most frequent
spontaneous event at a direct repeat [5,66]. Specifically, when
a DSB is formed between repeats, the ends are resected to
reveal 39 overhangs that can readily anneal to one another. As
we are primarily interested in conditions that stimulate
problems during replication, we designed the RaDR-GFP
substrate so that SSA is not detected (Figure 3 shows that SSA
gives rise to an expression cassette that harbors both of the
original deletions). This approach enables studies of sponta-
neous and exposure-induced HR events that are less frequent
at a direct repeat, yet biologically important, such as
replication fork repair. Taken together, both DSBs and broken
replication forks can lead to fluorescence in the RaDR-GFP
model, thus providing a window into how mammalian cells
respond to a broad range of conditions that impact genomic
stability by either suppressing or inducing HR in vivo.
To learn about spontaneous HR in vivo, we quantified
recombinant fluorescent cells in 11 different tissues and found
that recombinant cells are present in all tissues studied. The
frequency of recombinant cells is highly variable among tissues,
ranging from very low in the brain and stomach, to very frequent
in the pancreas and spleen. The observation that recombinant
cells are relatively frequent in the pancreas suggests that HR is
highly active in this organ (which is consistent with the studies of
aging; see below). Interestingly, mutations in BRCA2, which plays
a key role in initiating HR, are known to increase the risk of
pancreatic cancer [30,78]. Thus, for the pancreas, there is a
correlation between HR activity and the potential for a defect in
HR to contribute to cancer [79]. For some other tissues, the
frequency of HR is either unexpectedly high, or unexpectedly low.
In the case of the heart, which has a relatively low proliferative
index, there are a surprisingly high number of recombinant cells.
One possibility is that progenitor cells that gave rise to cardiac
tissue underwent HR, leading to the appearance of recombinant
fluorescent cells in the adult tissue. One way to differentiate HR
during development versus in the adult animal is to monitor tissue
during aging to see if HR is active in adult animals. In contrast to
cardiac tissue, the stomach had an unexpectedly low frequency of
recombinant cells. It is noteworthy that not all of the cells in the
disaggregated stomach tissue from the positive control mice were
fluorescent (,75% were positive by flow cytometry). This means
that for some cell types, HR will not give rise to fluorescence.
Although beyond the scope of this particular study, knowledge
about HR in specific cell types can be achieved through a
comparison of EGFP expression in RaDR-GFP mice (yielding
information about HR) and EGFP expression in the positive
Figure 7. HR events are induced by exposure to an exogenous
DNA damaging agent and are quantifiable using in-house
software. (A) Images of freshly excised liver and colon tissue from
control mice and from mice that were exposed to MNU/T3. (B) Images
of pancreata from control and MNU/T3 treated RaDR-GFP mice. (C)
Analysis of images from part (B) using in-house software to quantify
fluorescent foci. Foci identified by the program are indicated by ‘‘+’’. (D)
Frequencies of recombinant foci per cm2 in pancreatic, liver and colon
tissue quantified using in-house software (controls N= 7–8; treated
N=12–13). Brightness and contrast for all images were optimized for
publication. * p,0.05, Mann–Whitney U-test.
doi:10.1371/journal.pgen.1004299.g007
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control mice (yielding the baseline frequency of cells in which HR
can be detected).
As the RaDR-GFP mice age, the frequency of recombinant
somatic stem cells increases in the colon. Being able to monitor the
burden of recombinant cells is valuable for long-term studies of
conditions that impact HR. The burden of cells harboring
sequence changes is critical to cancer development since an
increase in the frequency of cells harboring a tumorigenic
mutation leads to an increased risk of subsequent tumor-
promoting mutations. Interestingly, exposure to MNU/T3
induced hundreds of recombination events in the RaDR-GFP
mice. In essence, the burden of recombinant cells in young DNA
damage-exposed mice is similar to aged mice, calling attention to
the burden of mutant cells as a commonality for these two key risk
factors for cancer. Being able to monitor HR over time and in
response to exposures shows that RaDR-GFP mouse model can be
used for studies of long-term exposures and physiological factors
that impact the burden of recombinant cells, thus providing
insights into fundamental processes that promote cancer.
A key advantage of fluorescence as a marker for HR is that it is
possible to reveal the underlying cell types that have undergone
HR. Using a fluorescent overlay on H&E images, we observed
fluorescent recombinant pancreatic acinar cells, liver hepatocytes
and colonic epithelial cells. Knowledge about genomic stability in
all three of these cell types is relevant to cancer. Although most
pancreatic carcinomas are thought to originate from ductal cells
[80], mutation of Kras in acinar cells can lead to neoplasia of the
ductal phenotype [81], and furthermore there is evidence that
acinar cells can undergo acinar to ductal transdifferentiation [82].
HR is also detectable in hepatocytes, which are precursors to
hepatocellular carcinomas. Additionally, being able to study
genetic change in vivo in the liver has broad implications, since
liver genotoxicity is a major barrier in drug development [83–85].
In the colon, we observed HR in colonic epithelial cells. Most
epithelial cells are rapidly sloughed off, making these cells unlikely
targets for initiating mutations for cancer. In contrast, colonic
somatic stem cells persist for years [72,73]. Our observation that
there are crypts in which all cells appear to be fluorescent is
consistent with an HR event in a somatic stem cell or early
daughter cell of that crypt. Interestingly, methods have previously
been developed for visualizing cells that have lost Dlb-1 gene
function in colon crypts [86]. In Dlb-1 heterozygous mice, LOH
can lead to a positive crypt by any of several different mechanisms
(e.g., point mutations, frameshifts, deletion, HR, etc.). An advantage
of the RaDR-GFP substrate is that it is designed to specifically
detect HR.
To learn about exposure-driven HR, we elected to exploit
an alkylating agent that provides insights into the biology of
cancer chemotherapeutics. The model agent MNU is an SN1
type methylating agent that generates methylated bases such as
3-methyladenine, 7-methylguanine and O6-methylguanine
[74]. Several methylating agents creating these lesions are
currently used in cancer chemotherapy including temozolo-
mide, which is used to treat metastatic melanoma and
malignant gliomas [87]. Importantly, HR activity contributes
to resistance to methylating agents used in the clinic [87].
Furthermore, HR induced in healthy tissues during treatment
with chemotherapeutic alkylating agents may be linked to
therapy-induced secondary cancers [88]. Because of the broad
reporter expression and sensitivity to methylation-induced HR,
the RaDR-GFP mice offer a new approach for probing the
extent to which treatments impact genomic stability both
within the tumor and within healthy tissues, which is relevant
to the risk of secondary cancers.
In addition to FYDR and RaDR-GFP mice, several other
mouse models that harness fluorescence as a marker for HR have
been developed, including the HPRTdupGFP, which is currently
in development in the Noda laboratory and promises to offer its
own advantages. In addition, the Jasin laboratory extended their
studies of DSB-induced HR in vitro to an animal model. The DR-
EGFP mice harbor a recombination reporter that carries
sequences for site-specific cleavage by I-SceI, and thus enable
studies of DSB-induced HR in cells cultured from that mouse [89].
Using this model, it has been shown that a deficiency in Brca1 leads
to reduced HR in cultured cells, and that DSB-induced HR can be
studied in various cell types in vitro using cells derived from
disaggregated tissues of the DR-EGFP mouse. While the use of a
homing endonuclease greatly increases the frequency of HR,
making it easier to quantify, the endonuclease needs to be
introduced in vitro, which is not compatible with studies of HR in
vivo. Furthermore, the DR-EGFP reporter is integrated into the
Pim-1 locus. In the absence of a positive control, it is not possible to
assess the relative frequency of HR among tissues, since a low
frequency of fluorescent cells may be due to either a lower rate of
HR or suppressed expression of EGFP. In contrast, for the RaDR-
GFP mice, it is possible to compare HR among tissues since the
number of cells that potentially express EGFP can be deduced
using a complementary positive control mouse line with the
identical locus and promoter. Unlike the DR-EGFP studies of HR
in cells that have been isolated from mice, the mice and the
methods described here enable analysis of HR in cells within their
normal tissue context in vivo, which enables studies of more
complex physiological processes, including cancer development
and chronic exposures.
Many mouse models have been developed for studies of point
mutations/small deletions in vivo (Pig-a, MutaMouse, Big Blue,
Plasmid lac-z, cII, Gpt-D [90–95]. For each of these mouse models,
as well as for the RaDR-GFP mice, susceptibility to sequence
changes is being monitored at a specific locus. Although
vulnerability to sequence changes is anticipated to be locus
dependent, these models nevertheless provide useful tools for
assessing the impact of genetic and environmental factors that
impinge on genomic stability. Unlike the transgenic models that
are used to study point mutations, the RaDR-GFP model exploits
fluorescence. The median frequency of fluorescent cells in RaDR-
GFP tissues is approximately ,2/105, whereas the frequency of
point mutations is much more rare (,1/108 per base pair) [1].
Consequently, strategies that exploit fluorescence to detect cells
that have undergone a specific point mutation within intact tissue
have not yet been described. Success in studies of point
mutagenesis has been achieved by isolating DNA from mouse
tissues, packaging the DNA into phage particles, and subsequently
detecting mutation events via phenotypic change in E. coli [91–95].
This process is laborious, expensive, slow, and significant expertise
is required in order to obtain reliable data, which together severely
limit the utility of these models. In contrast, analysis of
recombinant cells within intact RaDR-GFP tissue requires
minimal expertise, can be performed with standard fluorescent
microscopy, and requires much less time (e.g., processing one
RaDR-GFP tissue takes minutes, as opposed the many days that
are required for analysis of point mutations). Nevertheless, as the
underlying factors that modulate point mutagenesis are very
different from those that drive HR, methods that enable studies of
point mutations and HR are highly complementary.
Intensive research in the past decade has given rise to
sophisticated models for the molecular basis of HR, and has
revealed that imbalanced HR contributes to genomic instability
and cancer [75,96,97]. Here, we describe a novel mouse model
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that enables studies of HR in at least 11 different tissues. Here we
show that HR is pervasive among mammalian tissues, that the
frequency of HR is tissue-dependent, and that recombination
events accumulate with age. The RaDR-GFP mice open doors to
a wide range of studies. Knowledge about the extent to which HR
is normally active in different tissue types is relevant to our
understanding of how defects in HR lead to cancer in certain
tissues. By crossing with genetically engineered mice, it is now
possible to establish how specific genes impact HR throughout
mammalian tissues, and furthermore how HR capacity impinges
on cancer development. For example, the HR capacity of tumors
that are anticipated to be HR deficient (e.g., those that arise in a
Brca2+/2 mouse model) can potentially be formally tested in vivo
using the RaDR-GFP model. In terms of exposures, HR can be
monitored over time, which makes this model compatible with
studies of long-term environmental conditions that are relevant to
human cancer risk. Furthermore, this model can serve as a tool in
the development of cancer chemotherapeutics by providing a
window into tissue specific effects. In particular, the risk of
secondary cancers can be reduced by developing approaches that
induce HR and associated genotoxicity in the tumor, while
suppressing sequence rearrangements in healthy tissues. Addition-
ally, in terms of cancer treatment, the RaDR-GFP mice make it
possible to assess the efficacy of pharmaceutical agents that are
designed to either suppress or induce HR in a tumor-specific
fashion. Taken together, we have demonstrated how key
processes, including tissue context, aging and exposure to a
DNA damaging agent, impact the risk of HR in vivo. By creating
new avenues for studies of HR in multiple tissues, the work
described here enables future studies of genetic, environmental,
and clinical conditions that impact genomic stability in mammals.
Materials and Methods
Construction of the RaDR-GFP Substrate
Plasmid construction was described previously [66]. Briefly,
truncated EGFP coding sequences (D5egfp lacking 15 bases at the
59 end and D3egfp lacking 81 bases at the 39 end) were amplified by
PCR from plasmid pCX-EGFP, using primers that each insert
unique sequences. PCR products were cloned in a tandem
orientation (D5egfp followed by D3egfp) into the pCX-NNX
backbone to form the direct repeat HR substrate, yielding plasmid
pCX-NNX-DGF. The HR substrate was then cloned into pBigT-
TpA, released together with the neomycin resistance gene and
cloned into pRosa26PA [68] (a kind gift from Dr. P. Soriano,
Mount Sinai School of Medicine) to yield the targeting plasmid
pRosa26-DGF (Figure S1).
Creation of RaDR-GFP Transgenic Mouse
All animals were housed and handled in Association for
Assessment and Accreditation of Laboratory Animal Care
(AAALAC)-accredited facilities with diets, experimental methods,
and housing as specifically approved by the Institutional Animal
Care and Use Committee. The MIT CAC (IACUC) specifically
approved the studies as well as the housing and handling of these
animals.
The pRosa26-DGF targeting plasmid (Figure S1) was
linearized by digestion with XhoI (New England Biolabs) and
electroporated into mouse 129 embryonic stem (ES) cells.
Clones were selected for resistance to G418 by growing in
selective media (40% DMEM + glucose, 40% EmbryoMax
DMEM, 1% b- mercaptoethanol, 15% FBS, penicillin,
streptomycin, glutamine, nonessential amino acids, LIF,
G418) and screened for correct targeting by PCR and
Southern blot. Cells from clones with correct targeting were
injected into the blastocoel of 3.5-day-old C57BL/6 blasto-
cysts, which were implanted into pseudopregnant female mice.
All ES cell manipulations and transgenic mouse development
were performed by the ES Cell and Transgenics Facility at the
Swanson Biotechnology Center of the Koch Institute for
Integrative Cancer Research at MIT. All procedures involving
mice were approved by the Massachusetts Institute of
Technology Committee on Animal Care and in accordance
with the National Institutes of Health guidelines for the
humane care of animals.
PCR Analysis
To identify clones with correct targeting of the RaDR-GFP
substrate, we used a forward primer annealing 59 to the
targeted locus and a reverse primer landing in the neomycin
resistance gene within the construct, yielding a 1.24 kb PCR
product (Figure 1C). In the absence of insertion, the forward
primer yields a 1.16 kb PCR product with a reverse primer
landing within the Rosa26 locus (Figure 1C). All primer
sequences and exact PCR amplification conditions can be
found in Tables S1, S2, S3. PCR detection of the D5egfp,
D3egfp, and full-length EGFP sequences was performed as
described previously [66].
RNA Extraction and cDNA Conversion
Embryonic stem (ES) cells (104–106) or RaDR-GFP mouse
pancreatic cells (,1000) were lysed with 1 ml TRIzol (Life
Technologies) and either stored at 280uC or processed immedi-
ately. Total RNA was extracted and column purified using the
RNeasy Mini Kit (Qiagen). Briefly, TRIzol-lysed cells were mixed
with 200 ml chloroform and centrifuged at 12,000 g for 15 min at
4uC. The aqueous phase was mixed with 500 ml ice-cold
isopropanol and applied to an RNeasy column. The column was
washed based on the manufacturer’s protocol and RNA was eluted
with 30 ml RNase-free water. Total RNA (500–2000 ng) was
converted to cDNA with the SuperScript III First-Strand Synthesis
System for RT-PCR (Life Technologies) with both random
hexamers and oligo(dT). The volume was brought to 10 ml with
RNase-free water and incubated at 65uC for 5 min before placing
on ice for at least 1 min. Reverse transcriptase master mix was
added and the reaction was incubated at 25uC for 10 min, 50uC
for 50 min and 85uC for 5 min. Finally, E.coli RNase H (1 ml) was
added and the reaction was incubated at 37uC for 20 min to
remove RNA-cDNA duplexes before proceeding with PCR.
Direct PCR Analysis Using RNA Transcripts
PCR detection of full-length EGFP sequences was performed
with primers A FL FOR and C FL REV using Platinum Taq
DNA Polymerase (Life Technologies). 5 ml 106diluted cDNA was
used as the template in the presence of 0.2 mM primers and
enzyme mix according to the manufacturer’s instructions. cDNA
was denatured at 94uC for 3 min, and then incubated for 40 cycles
at 94uC for 45 s, 56uC for 45 s and 72uC for 1.5 min. Reactions
were then incubated at 72uC for 5 min and placed on ice. In order
to detect D5egfp and D3egfp, two primer sets were used in a single
reaction. Primers E D5 FOR2 and F D5 INT REV were used to
detect D5egfp, and primers G D3 INT FOR and H D3 REV2 were
used to detect D3egfp. Each reaction contained 0.2 mM primers.
PCR reactions were incubated at 94uC for 3 min, and then at
94uC for 45 s, 55uC for 30 s and 72uC for 1 min 10 s for 40 cycles.
Samples were incubated at 72uC for a final 5 min and placed on
ice.
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Nested PCR Analysis for Full-length EGFP
External PCR primers were designed to anneal upstream and
downstream of the EGFP coding sequence. Primers (0.2 mM)
BPEF3 and NEST Rev were added to Platinum Taq DNA
polymerase mix with 5 ml 106 diluted cDNA following the
manufacturer’s protocol. Reactions were incubated at 94uC for
3 min, and then for 40 cycles at 94uC for 45 s, 58uC for 30 s and
72uC for 1 min 10 s. Reactions were ended with incubation at
72uC for 5 min and then placed on ice. PCR products were
purified using the MinElute PCR Purification Kit (Qiagen) and
eluted with the same volumes of EB buffer. Purified PCR products
(5 ml) were used for subsequent full length EGFP PCR as described
above. PCR products were analyzed by 1.5% agarose gel
electrophoresis.
Single Cell Nested PCR Analysis
Single cells from RaDR mouse spleen were sorted by FACS into
5 ml lysis buffer (400 ng/ml proteinase K and 17 mM SDS in
nuclease-free water). As a control, a single colony of RaDR-GFP
ES cells was also added to lysis buffer. Cell lysates were freeze-
thawed once at 280uC, and added to a total volume of 50 ml
Platinum Taq DNA Polymerase (Life Technologies) mix with
0.2 mM primers BPEF3 and NEST Rev (Table S2). External PCR
was performed as described above. External PCR products (2–
5 ml) were then used for internal PCR as described above.
Southern Blot Analysis
The EGFP probing sequence was 32P-labeled by random
priming (NEBlot, New England Biolabs). Genomic DNA was
isolated from candidate clones and digested with HindIII (New
England Biolabs). DNA fragments were resolved by electropho-
resis and transferred to a nylon membrane (Hybond-XL, GE
Healthcare). The blot was incubated at 65uC in ExpressHyb (BD
Biosciences/Clontech) with the 32P-labeled EGFP probe. The
probed blot was visualized on a Storm 840 PhosphorImager
(Molecular Dynamics).
Positive Control Mouse
B6.Cg-Gt(ROSA)26Sortm6(CAG-ZsGreen1)Hze/J mice (Jackson
Laboratory) carry the green fluorescent protein gene ZsGreen1
at the Rosa26 locus driven by the CAG promoter, with an
upstream STOP codon flanked by loxP sites and a downstream
WPRE mRNA stabilizer. These mice were crossed with B6.C-
Tg(CMV-cre)1Cgn/J mice (Jackson Laboratory) that carry the
Cre recombinase gene driven by the CMV promoter, resulting in
the deletion of loxP-flanked sequences in all tissues including the
germline. Mice positive for both transgenes were then backcrossed
to C57BL/6J. The resulting Cre negative progeny expressing
ZsGreen1 under the CAG promoter at the Rosa26 locus were used
to determine the reporter expression profile. Mice were in the
C57BL/6 background, and were bred in house. All animals were
housed in pathogen free barrier facilities and treated humanely
with regard for alleviation of suffering.
Flow Cytometry
Tissues were kept in 0.01% trypsin inhibitor (Sigma) on ice for
up to 16 hours before analysis. Tissues were minced with scalpel
blades or with a gentleMACS tissue dissociator (Miltenyi Biotec)
and digested with 2 mg/ml collagenase V (Sigma) in HBSS
(Invitrogen) at 37uC for 45 min. After digestion, the cell
suspension was triturated and filtered through a 70 mm cell
strainer (BD Biosciences) into an equal volume of DMEM with
20% FBS on ice. Cells were pelleted at 1500 rpm for 10 minutes,
resuspended in OptiMEM (Invitrogen) and passed through a
35 mm cell strainer (BD Biosciences) before flow cytometry. Cells
were analyzed with a FACScan flow cytometer (BD Biosciences) or
sorted with a MoFlo cell sorter (Cytomation). Live cells were gated
using forward and side scatter and then examined for fluorescence
(excitation 488 nm, emission 580/30 nm). For RNA extraction
from spleen cells, 1000 EGFP positive or 1000 non-EGFP positive
cells were sorted into 200 ml TRIzol using a MoFlo (Cytomation)
or a FACSAria (BD Biosciences) cell sorter. TRIzol volumes were
then made up to 1 ml and cells were stored at 280uC until RNA
extraction.
In Situ Imaging of Recombinant Foci and Isolated Crypts
Whole organs were processed for imaging by compressing
between coverslips to a thickness of 0.5 mm. The colon was cut
lengthwise to expose the lumen. Tissues were imaged with a Nikon
80i microscope (61 objective) in the FITC channel using a fixed
exposure time. Serial images scanning the entire tissue surface
were captured using an automated stage. Images were automat-
ically compiled using NIS Elements software (Nikon) or Adobe
Photoshop (Adobe Systems). Brightness and contrast of all images
were adjusted identically in Adobe Photoshop. Fluorescent foci
were either counted manually in a blinded fashion or with an in-
house program written in MatLab (MathWorks). Tissue surface
area was determined using ImageJ (NIH) by manually tracing the
tissue outlines. Frozen sections (5 mm) were imaged with a 660
objective in the FITC channel, stained with hematoxylin and
eosin, and imaged again under visible light. Images were then
overlaid manually. For each estimate of the average number of
foci per cm2, the entire organ was evaluated in order to suppress
the impact of variations in foci number in different regions of each
organ.
Colonic crypts were isolated according to [98], with some
modifications. Briefly, tissue samples were washed with HBSS to
remove any fecal material. Dissected samples (0.5 to 1 cm2) were
treated with 1 mM EDTA, 0.05 mM dithiothreitol (Sigma) at
37uC. After incubation for 30 min, tissue samples were gently
shaken in the EDTA/DTT solution by inverting the tubes to
release epithelial cells. This process was repeated twice. Crypts
were stained with 1 mg/ml Hoechst 33342 (Invitrogen) and
imaged with an Axio Observer Z1 microscope (Zeiss) at 610 in
the brightfield, FITC, and DAPI channels. Crypt images were
captured using Axiovision Rel. 4.8 software (Zeiss) and compiled
with Image J 1.46r (NIH).
Automated Foci Counting
Images were preprocessed using median filtering, and intensity
shoots identified with an extended maxima transform [99] were
treated as foci candidates. Candidates were segmented using a
local thresholding-based algorithm where the threshold for each
focus was adaptively selected by modeling the focus as a two-
dimensional Gaussian distribution. Based on intensity and
morphological features extracted by preprocessing and segmenta-
tion, foci candidates were classified into true foci and noise, and
foci were further classified into large bright foci and small irregular
foci using a support vector machine (SVM) with a radial basis
function (RBF) kernel. The SVM was trained on annotations from
an experienced biologist over multiple images.
DNA Damage-Induced Recombination
Five- to seven-week-old heterozygous RaDR-GFP mice
(C57BL/6 background) were used. DNA damage was elicited by
combined treatment with N-methyl-N-nitrosourea (MNU, Sigma)
and thyroid hormone (T3, Sigma). Details will be published
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separately. Briefly, T3 was administered in the diet (prepared by
TestDiet) at 4 ppm according to [100]. MNU was administered at
25 mg/kg as an intraperitoneal injection at the time of peak cell
proliferation in the pancreas induced by T3. Control mice were
fed an identical diet without T3, and received control
PBS injections. Feeding of T3 continued for 2 days after
MNU injection. 3.5 weeks after MNU injection, mice were
humanely euthanized and organs were harvested for the RaDR-
GFP assay.
Statistics
Recombinant cell frequencies and foci frequencies do not follow
a normal distribution and were therefore compared using a two-
tailed Mann–Whitney test. A p value of less than 0.05 was
considered to be statistically significant.
Supporting Information
Figure S1 Design strategy for the RaDR-GFP targeting
construct.
(JPG)
Figure S2 Single-cell nested PCR analysis to identify
recombination classes. (A) Analysis of a single colony of
RaDR-GFP ES cells shows the presence of D3egfp and D5egfp,
but not full-length EGFP. (B) Nested PCR analysis of single
spleen cells. Tissue was disaggregated and green fluorescent
cells were isolated by FACS. In addition to full-length EGFP,
D3egfp and/or D5egfp were also detected, indicating that cells
had undergone HR through different pathways (see Figure 3
and text).
(TIF)
Table S1 Sequences for forward and reverse PCR primers that
specifically amplify full length EGFP, D3egfp and D5egfp. Sequences
are listed from 59 to 39.
(PDF)
Table S2 Sequences for flanking PCR primers used for nested
PCR.
(PDF)
Table S3 PCR conditions and product sizes.
(PDF)
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